tirzepatide idiopathic intracranial hypertension A new clinical trial will offer hope for people living with a debilitating, blinding headache condition Management of idiopathic intracranial hypertension

GLP-1s may be influencing breast cancer risk indirectly by improving some of the metabolic factors we know matter, including weight, insulin resistance, inflammation, and the hormonal environment, she told Healthline

Multi-agonists Targeting multiple pathways at once While GLP-1 receptors slow gastric emptying and increase satiety, other gut hormones like GIP (glucose-dependent insulinotropic polypeptide) and glucagon also influence energy balance

Tirzepatide can cause mild changes in heart rate, and in people who are very sensitive to bodily sensations, these changes may feel stronger or more alarming

Rated 5 out of 5 Communication was quick and practical